[Insulin-like activity determined as an antilipolytic effect of the serum in relation to obesity and fasting].
D000273:Adipose Tissue; D000328:Adult; D000818:Animals; D001769:Blood / Q000378:metabolism*; D003920:Diabetes Mellitus / Q000378:metabolism; D004837:Epinephrine / Q000494:pharmacology; D005215:Fasting; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005934:Glucagon / Q000494:pharmacology; D006801:Humans; D007328:Insulin / Q000097:blood*; D008875:Middle Aged; D009765:Obesity / Q000097:blood*
D005230:Fatty Acids, Nonesterified; D007328:Insulin; D005934:Glucagon; D004837:Epinephrine
Insulin-like aktivita stanovená jako antilipolytický efekt séra ve ztahu k obezitĕ a hladovĕní.